A drug with the SMILES CN1CCN(S(=O)(=O)c2cccc(S(=O)(=O)c3cccc(S(=O)(=O)N4CCN(C)CC4)c3)c2)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 2.644\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CN1CCN(S(=O)(=O)c2cccc(S(=O)(=O)c3cccc(S(=O)(=O)N4CCN(C)CC4)c3)c2)CC1
CN1CCN(S(=O)(=O)c2cccc(S(=O)(=O)c3cccc(S(=O)(=O)N4CCN(C)CC4)c3)c2)CC1
1-methyl-4-[3-[3-(4-methylpiperazin-1-yl)sulfonylphenyl]sulfonylphenyl]sulfonylpiperazine